Results 81 to 90 of about 136,879 (260)

Partial central diabetes insipidus after simultaneous pancreas-kidney transplantation exacerbated orthostatic hypotension in type 1 diabetes mellitus

open access: yesFujita Medical Journal, 2017
A 34-year-old woman with type 1 diabetes on hemodialysis was admitted to our hospital for simultaneous pancreas kidney transplantation received from her father.
Megumi Shibata   +7 more
doaj   +1 more source

Orthostatic Hypotension

open access: yesJournal of the American College of Cardiology, 2015
Orthostatic hypotension (OH) is a common cardiovascular disorder, with or without signs of underlying neurodegenerative disease. OH is diagnosed on the basis of an orthostatic challenge and implies a persistent systolic/diastolic blood pressure decrease of at least 20/10 mm Hg upon standing.
Ricci, F.   +2 more
openaire   +6 more sources

The Prevalence of Orthostatic Hypotension: A Systematic Review and Meta-Analysis

open access: yesThe journals of gerontology. Series A, Biological sciences and medical sciences, 2018
Background Orthostatic hypotension (OH) is associated with increased risk of falls, cognitive impairment and death, as well as a reduced quality of life. Although it is presumed to be common in older people, estimates of its prevalence vary widely.
N. Saedon, Maw Pin Tan, J. Frith
semanticscholar   +1 more source

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT‐1186‐A02)

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is approved in the US for the treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed IV edaravone slows the rate of physical functional decline.
Jeffrey Rothstein   +17 more
wiley   +1 more source

An Unusual Case of Neurogenic Orthostatic Hypotension Without Parkinsonian Features

open access: yesAnnals of Internal Medicine: Clinical Cases
Orthostatic hypotension is a common cause of syncope, especially in the older adult population. While it is a commonly encountered issue as a cause of syncope, neurogenic orthostatic hypotension (nOH) is less common.
Betul Gok Yavuz, Darian Fard, Asma Malik
doaj   +1 more source

Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer

open access: yesNeurological Therapeutics, 2019
Parkinson disease (PD) is associated with a variety of motor and non-motor clinical manifestations, including cardiovascular autonomic dysfunction.
J. Cutsforth-Gregory, P. Low
semanticscholar   +1 more source

Serious outcomes among emergency department patients with presyncope: A systematic review

open access: yesAcademic Emergency Medicine, EarlyView.
Abstract Background Syncope is transient loss of consciousness, and in presyncope, patients experience same prodromal symptoms without losing consciousness. While studies have extensively reported the risk of serious outcome among emergency department (ED) syncope, the outcome for patients with presyncope and their management are not well studied.
Hadi Mirfazaelian   +4 more
wiley   +1 more source

Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderly

open access: yesEuropean Journal of Neurology, 2019
Orthostatic hypotension is frequent with aging with a prevalence of 20%–30% in people aged 65 or older and is considered to increase the risk for coronary events, strokes and dementia.
M. Zimmermann   +11 more
semanticscholar   +1 more source

Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi   +4 more
wiley   +1 more source

Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease

open access: yesScientific Reports, 2017
We aimed to explore the effects of bilateral subthalamic nucleus stimulation and levodopa on cardiovascular autonomic function in Parkinson’s disease.
Kai Li   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy